NON-MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION (NST) IN PATIENTS WITH HIGH RISK LYMPHOMA: A SINGLE CENTRE EXPERIENCE

被引：0
|
作者：
Console, Giuseppe [1 ]
Messina, Giuseppe [1 ]
Martino, Massimo [1 ]
Morabito, Fortunato [1 ]
Irrera, Giuseppe [1 ]
Pucci, Giulia [1 ]
Penna, Giuseppa [1 ]
Cuzzola, Maria [1 ]
Iacopino, Olga [1 ]
Stelitano, Caterina [2 ]
Callea, Vincenzo [2 ]
Mamone, Domenico [3 ]
Kropp, Maria Grazia
Molica, Stefano [4 ]
Abbadessa, Antonio [5 ]
Iacopino, Pasquale [1 ]
机构：
[1] Azienda Osped Bianchi Melacrino Morelli, Ctr Trapianti Midollo Osseo, Reggio Di Calabria, Italy
[2] Azienda Osped Bianchi Melacrino Morelli, UO Ematol, Reggio Di Calabria, Italy
[3] Azienda Osped Papardo, UO Ematol, Messina, Italy
[4] Azienda Osped Pugliese Ciaccio, UO Oncol, Catanzaro, Italy
[5] Seconda Univ Napoli, Dipartimento Clin Internist & Sperimentale F Magr, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [31] Non-myeloablative allogeneic hematopoietic transplantation for patients with hematologic malignancies: 9-year single-centre experience
    Al Johani, N. I.
    Thompson, K.
    Hasegawa, W.
    White, D.
    Kew, A.
    Couban, S.
    CURRENT ONCOLOGY, 2014, 21 (03) : E434 - E440
  • [32] Allogeneic non-myeloablative stem cell transplantation for refractory rheumatoid arthritis
    Burt, R
    Oyama, Y
    Barr, W
    Traynor, A
    BONE MARROW TRANSPLANTATION, 2003, 31 : S145 - S146
  • [33] High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
    JR Passweg
    S Meyer-Monard
    M Gregor
    G Favre
    D Heim
    M Ebnoether
    A Tichelli
    A Gratwohl
    Bone Marrow Transplantation, 2002, 30 : 267 - 271
  • [34] Myeloablative vs non-myeloablative conditioning with allogeneic stem cell transplantation for high risk now Hodgkin's lymphoma: Similar outcomes despite differences in disease risk
    Hewitt, M
    Porter, DL
    Hummel, K
    McAlee, A
    Phillips, J
    Stadtmauer, E
    Schuster, S
    Luger, S
    Nasta, S
    Tsai, D
    Loren, A
    Perl, A
    Emerson, S
    Goldstein, SC
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 27 - 28
  • [35] Autologous stem cell transplantation followed by non-myeloablative allogeneic procedure for oncohaematologic patients
    Salas, G
    Jurado-Chacón, M
    Romero, A
    Almagro, M
    Lopez, P
    Moratalla, A
    Navarro, P
    De Pablos, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S328 - S329
  • [36] Allogeneic stem cell transplantation using non-myeloablative transplant regimens
    Körbling, M
    Khouri, I
    HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, : 175 - 184
  • [37] Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
    Yun, Tak
    Lee, Keun-Wook
    Song, Eun-Gi
    Na, Im-Il
    Shin, Hyun-Chun
    Yoon, Sung-Soo
    Park, Seon-Yang
    Kim, Byoung-Kook
    Lee, Jung-Hee
    Choi, Seong-Jun
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    CLINICAL TRANSPLANTATION, 2007, 21 (03) : 337 - 343
  • [38] Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancy
    Huugen, D
    Bos, GMJ
    Jansen, M
    Lalisang, R
    Jansen, R
    Wagstaff, J
    Schouten, HC
    NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (04): : 170 - 173
  • [39] Tandem Autologous/Non-Myeloablative Allogeneic Transplantation for High Risk Non-Hodgkin Lymphoma (NHL)
    Fakhri, Bita
    Cashen, Amanda
    Comer, Holly
    Abboud, Camille
    Westervelt, Peter
    DiPersio, John E.
    Stockerl-Goldstein, Keith
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S300 - S300
  • [40] Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
    Bahnson, R
    Hu, HS
    Vogelzang, NJ
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (01) : 79 - 81
12345